<DOC>
	<DOCNO>NCT00157859</DOCNO>
	<brief_summary>Multidrug resistant strain P.falciparum P.vivax become increasingly prevalent Asia Pacific rim . To determine efficacy locally recommend antimalarial protocol Papua , Indonesia , consecutive patient present rural clinic enrol prospective efficacy study . Patients uncomplicated falciparum malaria treat chloroquine plus sulfadoxine-pyrimethamine vivax malaria chloroquine monotherapy . Patients fail therapy receive unsupervised oral quinine +/- doxycycline 7 day . Follow-up continue 42 day falciparum malaria 28 day vivax malaria . The study hypothesis current recommend antimalarial protocol longer effective .</brief_summary>
	<brief_title>To Evaluate Current Efficacy Antimalarials Used Timika , Papua , Indonesia</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Malaria , Vivax</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<criteria>Male female patient least one 1year age weigh 10kg . Microscopic confirmation P. falciparum /or P.vivax infection ( parasitaemia ) . Fever ( axillary temperature &gt; 37.5oC ) history fever last 48 hour . Able participate trial comply clinical trial protocol Written inform consent participate trial ; verbal consent presence literate witness require illiterate patient , write consent parents/guardian child age consent Pregnancy lactation Inability tolerate oral treatment Signs/symptoms indicative severe/complicated malaria warn sign require parenteral treatment Known hypersensitivity allergy artemisinin derivative Serious underlying disease ( cardiac , renal hepatic ) Parasitaemia &gt; 4 %</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Falciparum</keyword>
	<keyword>Vivax</keyword>
	<keyword>Papua</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>Sulphadoxine-pyrimethamine</keyword>
</DOC>